Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aplastic anemia due to tocainide

M A Gertz, J P Garton, W H Jennings

    The New England Journal of Medicine
    |February 27, 1986
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    "Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.

    Blood cancer journal·2021
    Same author

    Systemic amyloidosis from A (AA) to T (ATTR): a review.

    Journal of internal medicine·2020
    Same author

    Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

    Leukemia·2019
    Same author

    Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

    Leukemia·2017
    Same author

    Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.

    Bone marrow transplantation·2017
    Same author

    Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.

    Leukemia·2017
    Same journal

    Advances in Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

    The New England journal of medicine·2026
    Same journal

    Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

    The New England journal of medicine·2026
    See all related articles